To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
June 5, 2009 > lincRNAs featured at recent Biology of Genomes conference
John L. Rinn, PhD (Damon Runyon-Rachleff Innovator ‘09-‘11) of Harvard Medical School and the Broad Institute, Boston, presented new findings on the function of lincRNAs (large intervening noncoding RNAs) at the May Biology of Genomes conference, Cold Spring Harbor. His team reported the identification of 4000 lincRNAs in the human genome. The functions of these lincRNAs are yet to be defined; however, one in particular is directly regulated by the tumor suppressor gene p53, indicating a potential role in controlling cancer.